AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia Substrate

RecruitingNAAges 18 Years - 85 YearsAllLiverpool Heart and Chest Hospital NHS Foundationโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Ventricular tachycardia (VT) is a life-threatening heart rhythm disorder and one of the commonest causes of heart-related sudden death. It often affects people who have had a heart attack or other structural heart damage. VT occurs when abnormal electrical circuits develop within and around scar tissue in the heart. People at risk are usually offered an implantable cardiac defibrillator (ICD), a device that can detect VT and deliver a lifesaving shock. While effective, these shocks can be sudden, painful and distressing. Medications such as amiodarone can also help, but they are often unsuitable for long-term use due to their potential side effects on the liver, lungs and thyroid gland. An alternative is catheter ablation. Thin tubes (catheters) are threaded from a blood vessel in the groin to the heart, allowing the cardiologist to identify scar tissue and abnormal electrical circuits

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Scheduled for clinically indicated VT ablation (due to sustained VT episodes or ICD therapies). * Willing and able to give informed consent for participation in the trial * Male or female aged between 18-85 * Ischaemic and non-ischaemic cardiomyopathy * ICD insitu Exclusion Criteria: * Unable or unwilling to consent * NYHA Class IV (end stage heart failure) * Metastatic cancer * End stage renal disease * Pregnant or breast feeding * Severe frailty
๐Ÿ’Š

What it tests

  • Dynamic Voltage Mapping
  • Standard of Care Ablation
๐Ÿ“

Where

1 site
Liverpool Heart and Chest Hospital NHS Foundation Trust
Liverpool, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy